| 英文别名 |
CB-839;CB839;Telaglenastat;U6CL98GLP4;2-(pyridin-2-yl)-N-(5-(4-(6-(2-(3-(trifluoromethoxy)phenyl)acetamido)pyridazin-3-yl)butyl)-1,3,4-thiadiazol-2-yl)acetamide;N-[6-[4-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide;2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-;2-Pyridineacetamide, N-(5-(4-(6-((2-(3-(trifluoromethoxy)phenyl)acet;2-(Pyridin-2-Yl)-N-(5-{4-[6-({[3-(Trifluoromethoxy)phenyl]acetyl}amino)pyridazin-3-Yl]butyl}-1,3,4-Thiadiazol-2-Yl)acetamide;N-[6-[4-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl;BRD-K58070273-001-03-3;BRD-K58070273-001-03-3;CHEBI:231605;CHEBI:231605;AKOS025396175;AKOS025396175;Q27075751;Q27075751;CHEMBL3639788;CHEMBL3639788;CB839; CB 839 pound>>Telaglenastat,;CB839; CB 839 pound>>Telaglenastat,;1439399-58-2;1439399-58-2;NSC-783415;NSC-783415;Telaglenastat (USAN/INN);Telaglenastat (USAN/INN);CCG-270102;CCG-270102;AC-31603;AC-31603;CB-839; N-[5-[4-[6-[[2-[3-(Trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide;CB-839; N-[5-[4-[6-[[2-[3-(Trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide;CS-3393;CS-3393;NSC783415;NSC783415;CB-839 [WHO-DD];CB-839 [WHO-DD];MFCD28167826;MFCD28167826;UNII-U6CL98GLP4;UNII-U6CL98GLP4;BCP28287;BCP28287;DA-34988;DA-34988;s7655;s7655;2-(PYRIDIN-2-YL)-N-{5-[4-(6-{2-[3-(TRIFLUOROMETHOXY)PHENYL]ACETAMIDO}PYRIDAZIN-3-YL)BUTYL]-1,3,4-THIADIAZOL-2-YL}ACETAMIDE;2-(PYRIDIN-2-YL)-N-{5-[4-(6-{2-[3-(TRIFLUOROMETHOXY)PHENYL]ACETAMIDO}PYRIDAZIN-3-YL)BUTYL]-1,3,4-THIADIAZOL-2-YL}ACETAMIDE;HMS3873G13;HMS3873G13;TELAGLENASTAT [INN];TELAGLENASTAT [INN];PRAAPINBUWJLGA-UHFFFAOYSA-N;PRAAPINBUWJLGA-UHFFFAOYSA-N;C26H24F3N7O3S;C26H24F3N7O3S;NSC795998;NSC795998;NSC-795998;NSC-795998;BDBM109086;BDBM109086;DB15232;DB15232;CB-839(Telaglenastat)?;CB-839(Telaglenastat)?;NCGC00356145-11;NCGC00356145-11;2-?Pyridineacetamide, N-?[5-?[4-?[6-?[[2-?[3-?(trifluoromethoxy)?phenyl]?acetyl]?amino]?-?3-?pyridaz;2-?Pyridineacetamide, N-?[5-?[4-?[6-?[[2-?[3-?(trifluoromethoxy)?phenyl]?acetyl]?amino]?-?3-?pyridaz;HY-12248;HY-12248;Telaglenastat [USAN];Telaglenastat [USAN];AS-75090;AS-75090;US8604016, 670;US8604016, 670;63J;63J;SCHEMBL14987180;SCHEMBL14987180;CB-839(Telaglenastat);CB-839(Telaglenastat);NSC-798057;NSC-798057;N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide;N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide;EX-A1310;EX-A1310;BRD-K58070273-001-04-1;BRD-K58070273-001-04-1;NSC798057;NSC798057;TELAGLENASTAT [WHO-DD];TELAGLENASTAT [WHO-DD];WHO 10815;WHO 10815;GTPL9053;GTPL9053;HMS3741E19;HMS3741E19;D11738;D11738;N-[6-(... |